BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30609649)

  • 1. Polymorphisms in
    Senghore T; Chien HT; Wang WC; Chen YX; Young CK; Huang SF; Yeh CC
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30609649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
    Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G
    Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.
    Senghore T; Wang WC; Chien HT; Chen YX; Young CK; Huang SF; Yeh CC
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
    Li Y; Liu Z; Liu H; Wang LE; Onodera H; Suzuki A; Suzuki K; Wadhwa R; Elimova E; Sudo K; Shiozaki H; Estrella J; Lee JS; Song S; Tan D; Ajani JA; Wei Q
    Carcinogenesis; 2014 Sep; 35(9):2031-8. PubMed ID: 24990617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of genetic variants XRCC1 rs1799782, APEX1 rs1760944, and MUTYH rs3219489 for adjuvant concurrent chemoradiotherapy outcomes in oral squamous cell carcinoma patients.
    Senghore T; Chien HT; Wang WC; Chen YX; Young CK; Huang SF; Yeh CC
    Pharmacogenomics J; 2020 Dec; 20(6):813-822. PubMed ID: 32461665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
    Sun Y; Wu Y; Li W; Kong Z; Zou X
    Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer.
    Liu J; Deng N; Xu Q; Sun L; Tu H; Wang Z; Xing C; Yuan Y
    Oncotarget; 2016 Jul; 7(30):48130-48142. PubMed ID: 27340861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of nonsynonymous SNPs of nucleotide excision repair genes ERCC4 rs1800067 (G/A) and ERCC5 rs17655 (G/C) as predisposing risk factors for gallbladder cancer.
    Anjali K; Kumar T; Kumar P; Narayan G; Singh S
    Dig Liver Dis; 2022 Nov; 54(11):1533-1540. PubMed ID: 35780063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
    Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of XRCC2 rs2040639 with the survival of patients with oral squamous cell carcinoma undergoing concurrent chemoradiotherapy.
    Senghore T; Wang WC; Chien HT; Chen YX; Young CK; Huang SF; Yeh CC
    Gene; 2021 Feb; 768():145283. PubMed ID: 33144272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
    Wang MJ; Zhu Y; Guo XJ; Tian ZZ
    Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma.
    Huang X; Liu C; Cui Y; Zhang H; Liu Y; Zhou X; Luo J
    Oncol Lett; 2017 Feb; 13(2):704-714. PubMed ID: 28356949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of nucleotide excision repair genes associated with colorectal cancer risk: Meta-analysis and trial sequential analysis.
    Yi C; Li T; Shen Y; Wang P; Dai L; Shi J; Wang K; Sun C; Ye H
    Front Genet; 2022; 13():1009938. PubMed ID: 36386844
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.
    Zhang GH; Ren JC; Luo M; Cui J; Du Y; Yang D; Cui S; Wang X; Wu W; Cao J; Xia ZL
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():13-20. PubMed ID: 30744808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk.
    Wang B; Xu Q; Yang HW; Sun LP; Yuan Y
    Oncotarget; 2016 Apr; 7(15):20357-67. PubMed ID: 26967386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.
    Zhang R; Zhou F; Cheng L; Yu A; Zhu M; Wang M; Zhang Z; Xiang J; Wei Q
    Mol Carcinog; 2018 Nov; 57(11):1553-1565. PubMed ID: 30035334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.